IL11 and minimally invasive lung adenocarcinoma: Treatment with BAC protects against IL-1β-induced inflammation in chondrocytes by elevating the expression of IL-11 through activating AP-1 transcriptional activity, indicating the therapeutic potential of BAC in patients with osteoarthritis (Yang et al., 2014).